WAT
49
2
SPG
48
2
CAT
58
-8
NOC
54
6
XYL
33
6
ECL
57
3
EMR
64
5
OI
47
-11
ALLE
44
3
REGN
59
2
BAC
77
5
NSC
48
-11
LMT
59
4
FOX
68
2
BF.B
48
-2
PH
62
2
TDC
70
3
SYF
74
5
CMI
71
2
WHR
50
-5
WAT
49
2
SPG
48
2
CAT
58
-8
NOC
54
6
XYL
33
6
ECL
57
3
EMR
64
5
OI
47
-11
ALLE
44
3
REGN
59
2
BAC
77
5
NSC
48
-11
LMT
59
4
FOX
68
2
BF.B
48
-2
PH
62
2
TDC
70
3
SYF
74
5
CMI
71
2
WHR
50
-5
Financhill
Back

Federated Hermes, Inc. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
70

FHI
Federated Hermes, Inc.

Last Price:
$52.65
Seasonality Move:
4.95%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
70
Federated Hermes, Inc. (FHI) is a Buy

Is Federated Hermes, Inc. a Buy, Sell or Hold?

  • The current Federated Hermes, Inc. [FHI] share price is $52.64. The Score for FHI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • FHI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FHI Stock Price Chart

What is Federated Hermes, Inc.'s stock price today?

  • The Federated Hermes, Inc. share price today is $52.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FHI is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

FHI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 63.72 Buy
Chaikin Money Flow: -904936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.79 - 52.01) Buy
Bollinger Bands (100): (49.62 - 53.04) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

FHI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.32 Buy
20-day SMA: 50.95 Buy
50-day SMA: 50.23 Buy
200-day SMA: 46.73 Buy
8-day EMA: 52.2 Buy
20-day EMA: 51.28 Buy
50-day EMA: 50.69 Buy
200-day EMA: 47.41 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Federated Hermes, Inc. Earnings Growth & FHI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.51 per share, and an increase next year of $0.19 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Federated Hermes, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):